Top Markets
Coin of the day
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd

688336
Pozycja w akcjach #3309
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd functions as a... Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd functions as a biopharmaceutical enterprise operating in China. This company is thoroughly engaged in the full lifecycle of antibody-based medicines, from their initial research and development to their production and subsequent market introduction. Its current portfolio includes YISAIPU, a tumor necrosis factor inhibitor utilized for treating rheumatic ailments; Xenopax, a recombinant humanized anti-CD25 monoclonal antibody delivered via injection; and Cipterbin, an anti-HER2 monoclonal antibody. Furthermore, the organization is actively progressing novel treatments designed for autoimmune disorders, various cancers, and other health issues. Established in 2002, its main offices are situated in Shanghai, China.
Cena akcji
$6.32
Kapitalizacja rynkowa
$5.66B
Zmiana (1 dzień)
0.30%
Zmiana (1 rok)
27.31%
Kraj
CN
Handel Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336)

Kategoria

Historia ceny akcji dla Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336)
Najwyższa cena zamknięcia: $6.78 dnia 2026-08-01

Najniższa cena zamknięcia: $4.81 dnia 2020-07-01
Historia cen akcji firmy Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd od 2020 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 5.66%
2025 188.76%
2024 -5.91%
2023 62.34%
2022 -30.84%
2021 -25.95%
2020 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$553.09 42.85%
US
$1.02K 44.02%
NL
$158.64 541.49%
US
$121.62 -12.98%
AU
$768.37 6.79%
CH